Clinical Trial Update: Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir [Phase 3]

View source ↗

Summary

Phase 3 trial comparing foscarnet to vidarabine for herpes infection in AIDS patients unresponsive to acyclovir has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Herpes Simplex

Drugs mentioned

• Foscarnet (foscarnet)
• vidarabine (vidarabine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex, HIV Infections | Phase 3 | Status: COMPLETED